MMIT - Managed Markets Insight & Technology

  • Home
  • MMIT - Managed Markets Insight & Technology

MMIT - Managed Markets Insight & Technology We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered.

06/04/2026

Is your message breaking through or getting lost in the noise? https://vist.ly/4xff2

MMIT’s Message Monitor gives you a “fly-on-the-wall” view into real conversations between payers, HCPs, and IDNs, so you can see exactly how your message resonates, where it stands against competitors, and what decision-makers really think. Now’s the time to fine-tune your story and strengthen your strategy before new coverage and formulary updates roll out.

Schedule a demo to gain insights into payer and IDN brand perception.

https://vist.ly/4xev8 | Payers don’t always respond to a brand’s differentiators as expected. In this study, learn how M...
06/04/2026

https://vist.ly/4xev8 | Payers don’t always respond to a brand’s differentiators as expected. In this study, learn how MMIT’s Message Monitor helped one biopharma company realize that payers were unimpressed with its clinical data, despite its brand’s novel MoA.

Download the case study by clicking on the link in this post.

04/04/2026

Market access data is table stakes. What matters is understanding what’s changing, why it’s changing, and how it impacts patients.

MMIT is purpose‑built to deliver that level of clarity, combining human intelligence with AI to provide context that teams can act on.

Download the infographic to see what MMIT delivers that others don’t: https://vist.ly/4xbfi

04/04/2026

If you want clarity—not noise—MMIT delivers the full picture.

In our latest video, we show how MMIT brings policy data, real-world data, AI, and human intelligence together to uncover what’s really happening between payer decisions and patient access.

See the real market access picture: https://vist.ly/4xaqw

03/04/2026

https://vist.ly/4x8sf | IT’s Payer Communication Program delivers custom reimbursement and coding updates to more than 80% of payers, as well as additional groups of providers, IDNs, and more. Read the case study for one pharma company’s story.

03/04/2026

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside?

With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights.

Meet with MMIT to learn more. Because guessing isn’t a strategy. https://vist.ly/4x7k4

02/04/2026

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside?

With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights.

Meet with MMIT to learn more. Because guessing isn’t a strategy. https://vist.ly/4x4qy

What’s keeping pharma executives up at night in 2026? We asked. We learned. Get the answers live at Asembia.Join MMIT’s ...
02/04/2026

What’s keeping pharma executives up at night in 2026? We asked. We learned. Get the answers live at Asembia.

Join MMIT’s Andrew Rouff and The Dedham Group’s Hannah Baxter on Tuesday, April 28, at 3 PM PT for their presentation, The State of Patient Access in 2026.

And don’t forget to stop by Booth 1415 to meet the MMIT team and start illuminating your patient access path. https://vist.ly/4x3nj

02/04/2026

https://vist.ly/4x39j | How do you get a clear view of the payer landscape—across regions, plans, and policies—when the details really matter?

In this use case, see how one manufacturer partnered with MMIT to gain the granular payer insights needed to navigate access across geographies.

01/04/2026

Employee spotlight! Meet Jason Rodman, an avid photographer whose work has been featured in magazines, books, and on TV. https://vist.ly/4wxfg

In his day job as VP of Client Partnership, Jason works with our company’s most complex clients, who typically have large brand portfolios spanning multiple therapeutic areas.

Congratulations to the finalists for the 2026 Patient Choice Awards! We are proud to honor these specialty pharmacies fo...
01/04/2026

Congratulations to the finalists for the 2026 Patient Choice Awards! We are proud to honor these specialty pharmacies for going the extra mile to provide excellent patient service.

The finalists are calculated based on the highest average net promoter scores (NPS) from quarterly Specialty Pharmacy Patient Satisfaction surveys throughout 2025.

Hospital & Health System Specialty Pharmacy:
• Arnot Health Specialty Pharmacy (Arnot Health, A Member of Centralus Health)
• Prisma Health Specialty Pharmacy (Prisma Health)
• Towers Specialty Pharmacy (Baptist Health Care)

Independent Specialty Pharmacy:
• FountainRx Specialty Pharmacy (FountainRx)
• Onco360 Oncology Pharmacy (Onco360 Oncology Pharmacy)
• PANTHERx® Rare Pharmacy

Infusion Specialty Pharmacy:
• 1st Option Home Infusion Pharmacy (1st Option Home Health & Infusion)
• Coram CVS Specialty Infusion Services (CVS Health)
• CSI Pharmacy (CSI Pharmacy)

Payer/PBM Specialty Pharmacy:
• CenterWell Specialty Pharmacy®
• CVS Specialty®
• Lumicera Health Services

Retail Specialty Pharmacy:
• Accord Specialty Pharmacy
• Walgreens Specialty Pharmacy
• Walmart Specialty Pharmacy

Specialty Pharmacy Hubs:
• AcariaHealth Specialty Pharmacy
• RareMed Solutions (RareMed Solutions)

Coverage shouldn’t feel like detective work. 🕵️By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork...
31/03/2026

Coverage shouldn’t feel like detective work. 🕵️

By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork and focus on what actually matters: patient access and informed decisions.

Clarity changes everything. Illuminate your path with MMIT today. https://vist.ly/4wtfx

Address


Telephone

+12677513162

Website

Alerts

Be the first to know and let us send you an email when MMIT - Managed Markets Insight & Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MMIT - Managed Markets Insight & Technology:

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Solving the What and the Why of Market Access

We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered. Physicians and pharmacies use our data and applications to understand what drugs are available to patients and how they are covered by health plans. Pharmaceutical manufacturers trust our data to understand how their drug and competitive drugs are covered, which helps forecast performance and tune strategy.